NCT03436212View on ClinicalTrials.gov

Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

March 6, 2018

Study Completion Date

March 6, 2018

Conditions

Type 2 Diabetes Mellitus

Interventions

DEVICE

Continuous Glucose Monitoring (CGM)

DEXCOMG4 device

Trial Locations (1)

14033

CHU de Caen, Service Endocrinologie, Diabétologie, Caen

All Listed Sponsors

lead

Air Liquide Santé International

INDUSTRY

NCT03436212 - Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. | Biotech Hunter | Biotech Hunter